Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 126, Issue 18
October 29 2015
Issue Cover

Table of Contents

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
aPTT in children receiving UFH: time for a change?
Clinical Trials & Observations
Riten Kumar,Sarah H. O’Brien
View Articletitled, aPTT in children receiving UFH: time for a change?
INSIDE BLOOD COMMENTARY
FOXP1 inhibits plasma cell differentiation
Kai-Michael Toellner
View Articletitled, FOXP1 inhibits plasma cell differentiation
INSIDE BLOOD COMMENTARY
Mutational landscape and complexity in CLL
Thorsten Zenz,Wolfgang Huber
View Articletitled, Mutational landscape and complexity in CLL
INSIDE BLOOD COMMENTARY
Oral NETs: the deadly kiss
Dominik Hartl
View Articletitled, Oral NETs: the deadly kiss
INSIDE BLOOD COMMENTARY
Expanding the binding model of DITP
Renhao Li
View Articletitled, Expanding the binding model of DITP
INSIDE BLOOD COMMENTARY
Granulocyte transfusion: questions remain
Jose A. Cancelas
View Articletitled, Granulocyte transfusion: questions remain

BLOOD SPOTLIGHT

HUS and the case for complement
Edward M. Conway
View Articletitled, HUS and the case for complement

CLINICAL TRIALS AND OBSERVATIONS

Monitoring unfractionated heparin in children: a parallel-cohort randomized controlled trial comparing 2 dose protocols
Clinical Trials & Observations
Andreas Hanslik,Erwin Kitzmüller,Ulrich S. Tran,Katharina Thom,Hratsch Karapetian,Nicole Prutsch,Jasmin Voitl,Ina Michel-Behnke,Fiona Newall,Christoph Male
View Articletitled, Monitoring unfractionated heparin in children: a parallel-cohort randomized controlled trial comparing 2 dose protocols

IMMUNOBIOLOGY

The forkhead transcription factor FOXP1 represses human plasma cell differentiation
Martine van Keimpema,Leonie J. Grüneberg,Michal Mokry,Ruben van Boxtel,Menno C. van Zelm,Paul Coffer,Steven T. Pals,Marcel Spaargaren
View Articletitled, The forkhead transcription factor FOXP1 represses human plasma cell differentiation
Supplemental data

LYMPHOID NEOPLASIA

Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL
Clinical Trials & Observations
Romain Guièze,Pauline Robbe,Ruth Clifford,Sophie de Guibert,Bruno Pereira,Adele Timbs,Marie-Sarah Dilhuydy,Maite Cabes,Loïc Ysebaert,Adam Burns,Florence Nguyen-Khac,Frédéric Davi,Lauren Véronèse,Patricia Combes,Magali Le Garff-Tavernier,Véronique Leblond,Hélène Merle-Béral,Reem Alsolami,Angela Hamblin,Joanne Mason,Andrew Pettitt,Peter Hillmen,Jenny Taylor,Samantha J. L. Knight,Olivier Tournilhac,Anna Schuh
View Articletitled, Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL
Supplemental data
Cell of origin of transformed follicular lymphoma
Robert Kridel,Anja Mottok,Pedro Farinha,Susana Ben-Neriah,Daisuke Ennishi,Yvonne Zheng,Elizabeth A. Chavez,Hennady P. Shulha,King Tan,Fong Chun Chan,Merrill Boyle,Barbara Meissner,Adele Telenius,Laurie H. Sehn,Marco A. Marra,Sohrab P. Shah,Christian Steidl,Joseph M. Connors,David W. Scott,Randy D. Gascoyne
View Articletitled, Cell of origin of transformed follicular lymphoma
Supplemental data

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

A novel mechanism for NETosis provides antimicrobial defense at the oral mucosa
Tirthankar Mohanty,Jonathan Sjögren,Fredrik Kahn,Anas H. A. Abu-Humaidan,Niels Fisker,Kristian Assing,Matthias Mörgelin,Anders A. Bengtsson,Niels Borregaard,Ole E. Sørensen
View Articletitled, A novel mechanism for NETosis provides antimicrobial defense at the oral mucosa
Supplemental data

PLATELETS AND THROMBOPOIESIS

Structural basis for quinine-dependent antibody binding to platelet integrin αIIbβ3
Jianghai Zhu,Jieqing Zhu,Daniel W. Bougie,Richard H. Aster,Timothy A. Springer
View Articletitled, Structural basis for quinine-dependent antibody binding to platelet integrin α<sub>IIb</sub>β<sub>3</sub>
Mechanism of quinine-dependent monoclonal antibody binding to platelet glycoprotein IIb/IIIa
Daniel W. Bougie,Julie Peterson,Mark Rasmussen,Richard H. Aster
View Articletitled, Mechanism of quinine-dependent monoclonal antibody binding to platelet glycoprotein IIb/IIIa

TRANSFUSION MEDICINE

Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection
Clinical Trials & Observations
Thomas H. Price,Michael Boeckh,Ryan W. Harrison,Jeffrey McCullough,Paul M. Ness,Ronald G. Strauss,W. Garrett Nichols,Taye H. Hamza,Melissa M. Cushing,Karen E. King,Jo-Anne H. Young,Eliot Williams,Janice McFarland,Jennifer Holter Chakrabarty,Steven R. Sloan,David Friedman,Samir Parekh,Bruce S. Sachais,Joseph E. Kiss,Susan F. Assmann
View Articletitled, Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection
Supplemental data

BLOOD WORK

Dividing plasma cells in the cerebrospinal fluid of a patient with refractory multiple myeloma
Nadav Sarid,Ben-Zion Katz
View Articletitled, Dividing plasma cells in the cerebrospinal fluid of a patient with refractory multiple myeloma
TAFRO syndrome or Castleman-Kojima syndrome: a variant of multicentric Castleman disease
Jennifer M. Hawkins,Vinodh Pillai
View Articletitled, TAFRO syndrome or Castleman-Kojima syndrome: a variant of multicentric Castleman disease

CORRESPONDENCE

Can a “center effect” explain the higher frequency of inhibitors for a second-generation recombinant factor VIII product?
H. Marijke van den Berg,On behalf of the PedNet Study Group,Rolf Ljung,On behalf of the PedNet Study Group
View Articletitled, Can a “center effect” explain the higher frequency of inhibitors for a second-generation recombinant factor VIII product?
Supplemental data
Is there more than one way to unpack a Weibel-Palade body?
Ianina L. Conte,Emma Cookson,Nicola Hellen,Ruben Bierings,Gregory Mashanov,Tom Carter
View Articletitled, Is there more than one way to unpack a Weibel-Palade body?
All Issues

Advertisement intended for health care professionals

Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of Diffuse Large B-cell Lymphoma
High-throughput drug screening identifies SMAC mimetics as enhancers of NK cell cytotoxicity in chronic myeloid leukemia
Donor Regulatory T-Cell Therapy to Prevent Graft-Versus-Host Disease
Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial
Doubling down on GPRC5D in multiple myeloma

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals